Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT04620018 |
Other study ID # |
1399 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
September 30, 2016 |
Est. completion date |
September 1, 2020 |
Study information
Verified date |
November 2020 |
Source |
Shiraz University of Medical Sciences |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Subjects who underwent a dental implant surgery were studied.Subjects randomly were aligned
into three groups:In group 1, subjects received prophylactic antibiotic orally (Amoxicillin
2mg ,1 hour before surgery) and post-surgical antibiotic (Amoxicillin 500 mg , q8h for five
days), subjects received only prophylactic antibiotic (Amoxicillin 2mg ,1 hour before
surgery) in group 2 ,and in group 3, subjects received post-surgical antibiotic (Amoxicillin
500 mg , q8h for five days). The sign and symptom of infection were studied and the incidence
of infection in each group was determined.
Description:
Subjects eligible for study inclusion had an edentulous area in the mandible or maxilla and
underwent a dental implant surgery. Subjects were excluded from study enrollment if they had
systemic diseases which affect bone metabolism, history of allergy to amoxicillin, refused
study enrollment or failed to return for follow-up.
Subjects were randomly divided into three groups : In group 1, subjects received prophylactic
antibiotic orally (Amoxicillin 2mg ,1 hour before surgery) and post-surgical antibiotic
(Amoxicillin 500 mg , q8h for five days), subjects received only prophylactic antibiotic
(Amoxicillin 2mg ,1 hour before surgery) in group 2 ,and in group 3, subjects received
post-surgical antibiotic (Amoxicillin 500 mg , q8h for five days) . An independent researcher
made random allocation cards using computer-generated random. Then, allocated cases were
placed in a sealed envelope. All subjects used 0.2% chlorhexidine mouthwash in the treatment
period. All implants were placed with a two-stage protocol.
All subjects were followed up for 3 months to assess any infection signs and symptoms.
Infection was diagnosed based on clinical findings such as pain, redness of the area, and
discharge around the fixture.An independent dentist who was blind the study groups, evaluated
all subjects.